RVL-1201

· RVL Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for RVL-1201, covering 2020-09-16 to 2021-07-22. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of RVL-1201 in Acquired Blepharoptosis [Phase 1, Phase 2]